EQUASHIELD® Named Most-Used CSTD in the U.S. for Eighth Consecutive Year

In a healthcare environment where safety, consistency, and staff protection are non‑negotiable, EQUASHIELD® continues to ...
Le Lézard

EQUASHIELD® Marks Earth Day with Transition to eIFU, Advancing Sustainability Across Operations

PORT WASHINGTON, N.Y., April 22, 2026 /PRNewswire/ -- In recognition of Earth Day 2026, EQUASHIELD ®, a global leader in hazardous drug handling, today announced its transition to electronic ...
WBTW

EQUASHIELD® Launches CellSHIELD®: A New Era in Cell and Gene Therapy Manufacturing

CellSHIELD ® addresses critical challenges in cell and gene therapy manufacturing by reducing cost, improving efficiency, and supporting product safety. Its fully closed design ensures sterility and ...
Le Lézard

EQUASHIELD® Ranked #1 Closed System Transfer Device in US Pharmacies for 7th Consecutive Year

PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...